Drug
Magtrace
Magtrace is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph not_applicable
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Enrolling by invitation1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown120%
enrolling_by_invitation120%
completed120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_2
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
NCT06868238
recruiting
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
NCT06104371
enrolling_by_invitationnot_applicable
MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer
NCT06273501
completed
Magseed and Magtrace Localization for Breast Cancer
NCT05161507
unknownnot_applicable
Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer
NCT05375526
Clinical Trials (5)
Showing 5 of 5 trials
NCT06868238Phase 2
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
NCT06104371
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
NCT06273501Not Applicable
MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer
NCT05161507
Magseed and Magtrace Localization for Breast Cancer
NCT05375526Not Applicable
Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5